Then, we demonstrated that PTBP1 knock‐down enhanced the chemosensitivity of cisplatin‐resistant osteosarcoma cells to cisplatin by directly up‐regulating the expression level of SLC31A1. Here, SLC31A1 is linked to osteosarcoma.